GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP)

Market Open
11 Sep, 14:45
NASDAQ (CM) NASDAQ (CM)
$
7. 43
+1.25
+20.178%
$
6.61M Market Cap
- P/E Ratio
- Div Yield
106,901 Volume
-10.8 Eps
$ 6.18
Previous Close
Add Transaction
Day Range
6.59 7.78
Year Range
4.91 34.25
Want to track GTBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

GT Biopharma, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
500 $245 $3,820 $3,575 1,459.18%
Donna Rittershausen
Donna Rittershausen Koss-Olinger Consulting LLC
400 $4,900 $2,968 -$1,932 -39.43%
Richard Slavik
Richard Slavik Newbridge Financial Services Group Inc.
150 $9,504.5 $1,113 -$8,391.5 -88.29%
CGL
Chester Gary Lloyd Coston, McIsaac & Partners
683.68 $13,417.22 $5,004.54 -$8,412.68 -62.7%
Vincent Incerto
Vincent Incerto LaSalle St. Investment Advisors LLC
440 $4,488 $3,400.23 -$1,087.77 -24.24%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
120 $2,355.96 $880.5 -$1,475.46 -62.63%
KPL
Kitching Partners LLC KITCHING PARTNERS, LLC
2,000 $24,486 $14,700 -$9,786 -39.97%
Alan Gilmore
Alan Gilmore Private Wealth Management Group, LLC
800 $8,162.4 $5,242 -$2,920.4 -35.78%
Kevyn Hill
Kevyn Hill Hilltop National Bank
4 $41 $29.4 -$11.6 -28.29%
Dan Wohlgemuth
Dan Wohlgemuth 49 WEALTH MANAGEMENT, LLC
2,560 $31,342.08 $20,518.4 -$10,823.68 -34.53%
RFA
Reyes Financial Architecture Inc. Reyes Financial Architecture Inc.
25 $306 $129.75 -$176.25 -57.6%